首页 > 最新文献

Gynecologie Obstetrique Fertilite & Senologie最新文献

英文 中文
Analyse d’une cohorte française d’encéphalopathies néonatales anoxo-ischémiques à l’ère de l’hypothermie thérapeutique : questions–réponses [法国新生儿缺氧缺血性脑病队列在治疗性低温时代的调查:问题与答案]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.gofs.2024.02.025
Thierry Debillon , Jonathan Beck , Isabelle Guellec , Antoine Vilotitch , Véronique Pierrat , Olivier Baud , Loïc Sentilhes , Gilles Kayem , Anne Ego

Objective

To improve knowledge of neonatal hypoxic-ischemic encephalopathy, a prospective, nationwide, population-based cohort of affected children is being set up between September 2015 and March 2017.

Methods

During this period, 794 cases are collected, with information on pregnancy, delivery, neonatal stay and outcome at the end of hospitalization. Clinical and parental questionnaire follow-up is planned until the child is 4 years old.

Results

This article presents the clinical presentation of the newborns included, the analysis of factors associated with short-term outcome at hospital discharge and the organizational factors associated with treatment with therapeutic hypothermia.

Conclusion

These data illustrate the value of a prospective cohort to analyze the management of anoxo-ischemic encephalopathy in France.

目的:为了提高对新生儿缺氧缺血性脑病的认识,2015年9月至2017年3月期间,正在建立一个前瞻性的、全国性的、以人群为基础的患儿队列。方法:在此期间,收集了794个病例,包括怀孕、分娩、新生儿住院和住院结束时的结果等信息。结果:本文介绍了所纳入新生儿的临床表现、与出院时短期疗效相关的因素分析以及与治疗性低温疗法相关的组织因素。结论:这些数据说明了前瞻性队列在分析法国 EAI 管理方面的价值。
{"title":"Analyse d’une cohorte française d’encéphalopathies néonatales anoxo-ischémiques à l’ère de l’hypothermie thérapeutique : questions–réponses","authors":"Thierry Debillon ,&nbsp;Jonathan Beck ,&nbsp;Isabelle Guellec ,&nbsp;Antoine Vilotitch ,&nbsp;Véronique Pierrat ,&nbsp;Olivier Baud ,&nbsp;Loïc Sentilhes ,&nbsp;Gilles Kayem ,&nbsp;Anne Ego","doi":"10.1016/j.gofs.2024.02.025","DOIUrl":"10.1016/j.gofs.2024.02.025","url":null,"abstract":"<div><h3>Objective</h3><p>To improve knowledge of neonatal hypoxic-ischemic encephalopathy, a prospective, nationwide, population-based cohort of affected children is being set up between September 2015 and March 2017.</p></div><div><h3>Methods</h3><p>During this period, 794 cases are collected, with information on pregnancy, delivery, neonatal stay and outcome at the end of hospitalization. Clinical and parental questionnaire follow-up is planned until the child is 4 years old.</p></div><div><h3>Results</h3><p>This article presents the clinical presentation of the newborns included, the analysis of factors associated with short-term outcome at hospital discharge and the organizational factors associated with treatment with therapeutic hypothermia.</p></div><div><h3>Conclusion</h3><p>These data illustrate the value of a prospective cohort to analyze the management of anoxo-ischemic encephalopathy in France.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 7","pages":"Pages 473-480"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140013807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
L’étiologie de la pré-éclampsie est-elle vraiment placentaire ? 先兆子痫的病因真的是胎盘吗?
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.gofs.2024.06.001
Emmanuel Simon
{"title":"L’étiologie de la pré-éclampsie est-elle vraiment placentaire ?","authors":"Emmanuel Simon","doi":"10.1016/j.gofs.2024.06.001","DOIUrl":"https://doi.org/10.1016/j.gofs.2024.06.001","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 7","pages":"Pages 443-445"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141484058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sommaire 目录
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/S2468-7189(24)00239-3
{"title":"Sommaire","authors":"","doi":"10.1016/S2468-7189(24)00239-3","DOIUrl":"https://doi.org/10.1016/S2468-7189(24)00239-3","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 7","pages":"Page v"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468718924002393/pdfft?md5=a5acb2508a128ba4754064640832d2e3&pid=1-s2.0-S2468718924002393-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141484057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Le neurodéveloppement et la neuroprotection du jeune enfant [幼儿的神经发育和神经保护]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.gofs.2024.03.003
Stéphane Marret , Alexandra Chadie , Jean-Baptiste Muller , Clément Chollat

In France, the most pessimistic estimates put the prevalence of neurodevelopmental disorders (NDD) at 15 % of births. The two largest populations of newborns at highest risk of NDD are premature babies and babies born into siblings with one or more infants who already have an autism spectrum disorder or another NDD. The high prevalence of these disorders justifies a health promotion policy, centred on the child and his or her family. Prevention is based on the early identification of high-risk factors, by informing families and training pregnancy and early childhood professionals, and implementing perinatal prevention protocols for high-risk newborns (antenatal corticosteroid therapy and magnesium sulfate for women at risk of preterm delivery before 32 weeks, developmental care, therapeutic hypothermia for full-term infants with early neonatal encephalopathy presumed to be anoxic). Preventing the severity of NDD depends on their early identification, as early as possible in the highest plastic “1000 days” developmental window, a smooth flow of diagnosis and care for mothers and children, and the establishment of an ecosystem that includes multi-modal early intervention, at the best in multi-disciplinary teams such as the early medical and social action centres, support for families through guidance programs and inclusion in the community, first in day-care centers and then in nursery schools.

在法国,根据最悲观的估计,神经发育障碍(NDD)的发病率占新生儿的 15%。患神经发育障碍风险最高的两大新生儿群体是早产儿和兄弟姐妹中有一人或多人患有自闭症谱系障碍或其他神经发育障碍的婴儿。这些疾病的高发病率证明,有必要采取以儿童及其家庭为中心的健康促进政策。预防的基础是及早发现高危因素,方法是告知家庭并培训孕期和幼儿期专业人员,对高危新生儿实施围产期预防方案(对 32 周前有早产风险的妇女进行产前皮质类固醇治疗和硫酸镁治疗、发育护理、对推测为缺氧性新生儿早期脑病的足月婴儿进行治疗性低温)。预防新生儿缺氧性脑病的严重程度取决于早期识别,在可塑性最高的 "1000 天 "发育窗口期尽早识别,为母亲和儿童提供顺畅的诊断和护理流程,并建立一个生态系统,其中包括多模式早期干预,最好是由多学科团队(如早期医疗和社会行动中心)进行干预,通过指导方案为家庭提供支持,并融入社区,首先是日托中心,然后是幼儿园。
{"title":"Le neurodéveloppement et la neuroprotection du jeune enfant","authors":"Stéphane Marret ,&nbsp;Alexandra Chadie ,&nbsp;Jean-Baptiste Muller ,&nbsp;Clément Chollat","doi":"10.1016/j.gofs.2024.03.003","DOIUrl":"10.1016/j.gofs.2024.03.003","url":null,"abstract":"<div><p>In France, the most pessimistic estimates put the prevalence of neurodevelopmental disorders (NDD) at 15 % of births. The two largest populations of newborns at highest risk of NDD are premature babies and babies born into siblings with one or more infants who already have an autism spectrum disorder or another NDD. The high prevalence of these disorders justifies a health promotion policy, centred on the child and his or her family. Prevention is based on the early identification of high-risk factors, by informing families and training pregnancy and early childhood professionals, and implementing perinatal prevention protocols for high-risk newborns (antenatal corticosteroid therapy and magnesium sulfate for women at risk of preterm delivery before 32 weeks, developmental care, therapeutic hypothermia for full-term infants with early neonatal encephalopathy presumed to be anoxic). Preventing the severity of NDD depends on their early identification, as early as possible in the highest plastic “1000 days” developmental window, a smooth flow of diagnosis and care for mothers and children, and the establishment of an ecosystem that includes multi-modal early intervention, at the best in multi-disciplinary teams such as the early medical and social action centres, support for families through guidance programs and inclusion in the community, first in day-care centers and then in nursery schools.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 7","pages":"Pages 481-489"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140141224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Les forums de discussion dédiés au cancer du sein peuvent-ils être utiles aux soignants ? Analyse des messages initiaux du forum de la Ligue nationale contre le cancer pendant une année [乳腺癌健康论坛对护理人员有用吗?对全国抗癌联盟论坛一年来初始信息的分析]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.gofs.2024.02.003
Hélène Burgué , Philippe Trensz , Carole Mathelin , Anna Schohn

Objectives

Forums are a source of health information and exchange. They can be studied to determine patients’ needs and improve caregivers’ practices. The aim of this study was to identify the needs of breast cancer patients based on messages posted on a discussion forum.

Methods

Initial messages posted in 2021 on the Ligue nationale contre le cancer (LNCC) breast cancer forum were analyzed quantitatively. Message content was classified into three categories: testimonial, request for advice or request for medical opinion. The tone of the message (positive, neutral, or negative) was recorded. The temporality of the illness during which the patient expressed herself was defined. Analysis was carried out on the initial messages using the Chi2, Fisher, and Kruskal-Wallis tests, with a significance level of < 0.05.

Results

In 2021, 640 initial messages posted on the LNCC forum dedicated to breast cancer were analyzed. Messages were posted by 312 authors, including 275 patients and 37 family members. Three main types of messages were identified: requests for medical advice (n = 339), advice (n = 164), and testimonials (n = 137). Requests for medical advice elicited fewer responses than testimonials (P < 0.001). A need for supportive care was identified in 42.8% of messages, mostly concerning social (17.3%) and psychological (13%) care.

Conclusion

Our study revealed a need for more information especially regarding the social impact of the disease and the side-effects of treatment. The period of greatest need of information was the diagnostic waiting time. However, patients using discussion forums are not representative of all women with breast cancer and our results should not be generalized to all patients treated for breast cancer.

目的:论坛是健康信息和交流的来源。通过对论坛进行研究,可以确定患者的需求并改进护理人员的工作。本研究旨在根据论坛上发布的信息确定乳腺癌患者的需求:对 2021 年发布在全国抗癌联盟(LNCC)乳腺癌论坛上的初始信息进行了定量分析。信息内容分为三类:推荐信、咨询请求或医疗意见请求。信息的语气(正面、中性或负面)也被记录下来。对患者表达自己观点的疾病时间进行了界定。使用 Chi2、Fisher 和 Kruskal-Wallis 检验对初始信息进行分析,显著性水平为 <0.05:分析了 2021 年在 LNCC 乳腺癌论坛上发布的 640 条初始信息。共有 312 位作者发布了信息,其中包括 275 位患者和 37 位家属。确定了三种主要类型的信息:医疗建议请求(339 条)、建议(164 条)和推荐(137 条)。与推荐信相比,医疗建议请求得到的回复较少(p < 0.001)。42.8%的信息表明需要支持性护理,主要涉及社会护理(17.3%)和心理护理(13%):我们的研究表明,人们需要更多的信息,尤其是关于疾病的社会影响和治疗副作用的信息。最需要信息的时期是诊断等待时间。然而,使用论坛的患者并不代表所有乳腺癌女性患者,我们的研究结果也不能推广到所有接受治疗的乳腺癌患者。
{"title":"Les forums de discussion dédiés au cancer du sein peuvent-ils être utiles aux soignants ? Analyse des messages initiaux du forum de la Ligue nationale contre le cancer pendant une année","authors":"Hélène Burgué ,&nbsp;Philippe Trensz ,&nbsp;Carole Mathelin ,&nbsp;Anna Schohn","doi":"10.1016/j.gofs.2024.02.003","DOIUrl":"10.1016/j.gofs.2024.02.003","url":null,"abstract":"<div><h3>Objectives</h3><p>Forums are a source of health information and exchange. They can be studied to determine patients’ needs and improve caregivers’ practices. The aim of this study was to identify the needs of breast cancer patients based on messages posted on a discussion forum.</p></div><div><h3>Methods</h3><p>Initial messages posted in 2021 on the <em>Ligue nationale contre le cancer</em> (LNCC) breast cancer forum were analyzed quantitatively. Message content was classified into three categories: testimonial, request for advice or request for medical opinion. The tone of the message (positive, neutral, or negative) was recorded. The temporality of the illness during which the patient expressed herself was defined. Analysis was carried out on the initial messages using the Chi<sup>2</sup>, Fisher, and Kruskal-Wallis tests, with a significance level of<!--> <!-->&lt;<!--> <!-->0.05.</p></div><div><h3>Results</h3><p>In 2021, 640 initial messages posted on the LNCC forum dedicated to breast cancer were analyzed. Messages were posted by 312 authors, including 275 patients and 37 family members. Three main types of messages were identified: requests for medical advice (<em>n</em> <!-->=<!--> <!-->339), advice (<em>n</em> <!-->=<!--> <!-->164), and testimonials (<em>n</em> <!-->=<!--> <!-->137). Requests for medical advice elicited fewer responses than testimonials (<em>P</em> <!-->&lt;<!--> <!-->0.001). A need for supportive care was identified in 42.8% of messages, mostly concerning social (17.3%) and psychological (13%) care.</p></div><div><h3>Conclusion</h3><p>Our study revealed a need for more information especially regarding the social impact of the disease and the side-effects of treatment. The period of greatest need of information was the diagnostic waiting time. However, patients using discussion forums are not representative of all women with breast cancer and our results should not be generalized to all patients treated for breast cancer.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 7","pages":"Pages 466-472"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139718095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Facteurs de risque de lésions malpighiennes intra-épithéliale de haut grade ou de cancer du col de l’utérus en cas de maladie inflammatoire chronique de l’intestin [慢性炎症性肠病高级别鳞状上皮内病变或宫颈癌的风险因素]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.gofs.2024.01.008
Clémence Dujardin , Thibault Balcaen , Antoine Vanoost , Denis Chatelain , Jean Gondry , Mathurin Fumery , Arthur Foulon

Introduction

Chronic inflammatory bowel disease (IBD) is thought to increase the risk of high-grade histological intraepithelial lesions (HGIL) and cervical cancer. The risk factors for developing these lesions are poorly understood.

Materials and methods

This is a single-center retrospective case-control study including IBD patients followed at our University Hospital Center from 2011 to 2021 who presented with HGIL or cervical cancer. Four controls were case-matched according to IBD type, age, active smoking and multiparity.

Results

Eighteen cases and 72 controls were included. We found no significant differences between the 2 groups with regard to mean age at IBD diagnosis, mean duration of IBD, IBD location, history of IBD-related surgery or even association with another chronic inflammatory disease. In our study, the use of immunosuppressants/biotherapies in these patients [50% (9/18) for cases vs. 56% (40/72) for controls; P = 0.9] was not a risk factor for IGRA or cervical cancer. Similarly, neither the total duration of exposure to immunosuppressants/biotherapies (9.9 ± 8 years for cases vs. 6.6 ± 5.3 years for controls; P = 0.1), nor combined therapies [11% (2/18) for cases vs. 6% (4/72) for controls; P = 0.3], nor azathioprine or methotrexate use [22% (4/18) for cases vs. 11% (8/72) for controls; P = 0.3] were found to be risk factors.

Conclusion

In our study, we found no risk factors for patients with IBD to develop IGRA or cervical cancer.

导言:慢性炎症性肠病(IBD)被认为会增加高级别组织学上皮内病变(HGIL)和宫颈癌的发病风险。目前对发生这些病变的风险因素还知之甚少:这是一项单中心回顾性病例对照研究,研究对象包括 2011 年至 2021 年在本大学医院中心随访的 IBD 患者,这些患者均出现 HGIL 或宫颈癌。根据IBD类型、年龄、主动吸烟和多胎性,对4名对照者进行了病例匹配:结果:共纳入 18 例病例和 72 例对照。我们发现,两组患者在确诊 IBD 的平均年龄、IBD 的平均持续时间、IBD 的部位、IBD 相关手术史甚至与其他慢性炎症性疾病的关联方面均无明显差异。在我们的研究中,这些患者使用免疫抑制剂/生物疗法(病例为 50%(9/18),对照组为 56%(40/72);P=0.9)并不是 IGRA 或宫颈癌的危险因素。同样,无论是使用免疫抑制剂/生物疗法的总时间(病例为9,9±8年;对照组为6,6±5.3年;P=0.1),还是联合疗法(病例为11%(2/18);对照组为6%(4/72);P=0.3),还是硫唑嘌呤或甲氨蝶呤的使用(病例为22%(4/18);对照组为11%(8/72);P=0.3),都不是风险因素:在我们的研究中,没有发现 IBD 患者罹患 IGRA 或宫颈癌的风险因素。
{"title":"Facteurs de risque de lésions malpighiennes intra-épithéliale de haut grade ou de cancer du col de l’utérus en cas de maladie inflammatoire chronique de l’intestin","authors":"Clémence Dujardin ,&nbsp;Thibault Balcaen ,&nbsp;Antoine Vanoost ,&nbsp;Denis Chatelain ,&nbsp;Jean Gondry ,&nbsp;Mathurin Fumery ,&nbsp;Arthur Foulon","doi":"10.1016/j.gofs.2024.01.008","DOIUrl":"10.1016/j.gofs.2024.01.008","url":null,"abstract":"<div><h3>Introduction</h3><p>Chronic inflammatory bowel disease (IBD) is thought to increase the risk of high-grade histological intraepithelial lesions (HGIL) and cervical cancer. The risk factors for developing these lesions are poorly understood.</p></div><div><h3>Materials and methods</h3><p>This is a single-center retrospective case-control study including IBD patients followed at our University Hospital Center from 2011 to 2021 who presented with HGIL or cervical cancer. Four controls were case-matched according to IBD type, age, active smoking and multiparity.</p></div><div><h3>Results</h3><p>Eighteen cases and 72 controls were included. We found no significant differences between the 2 groups with regard to mean age at IBD diagnosis, mean duration of IBD, IBD location, history of IBD-related surgery or even association with another chronic inflammatory disease. In our study, the use of immunosuppressants/biotherapies in these patients [50% (9/18) for cases vs. 56% (40/72) for controls; <em>P</em> <!-->=<!--> <!-->0.9] was not a risk factor for IGRA or cervical cancer. Similarly, neither the total duration of exposure to immunosuppressants/biotherapies (9.9<!--> <!-->±<!--> <!-->8<!--> <!-->years for cases vs. 6.6<!--> <!-->±<!--> <!-->5.3<!--> <!-->years for controls; <em>P</em> <!-->=<!--> <!-->0.1), nor combined therapies [11% (2/18) for cases vs. 6% (4/72) for controls; <em>P</em> <!-->=<!--> <!-->0.3], nor azathioprine or methotrexate use [22% (4/18) for cases vs. 11% (8/72) for controls; <em>P</em> <!-->=<!--> <!-->0.3] were found to be risk factors.</p></div><div><h3>Conclusion</h3><p>In our study, we found no risk factors for patients with IBD to develop IGRA or cervical cancer.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 7","pages":"Pages 460-465"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468718924000126/pdfft?md5=6571d35b3659fdf91bc30a791741452e&pid=1-s2.0-S2468718924000126-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139547761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence de l’immersion dans l’eau sur le recours à la péridurale pendant le travail [浸水对分娩期间使用硬膜外麻醉的影响]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.gofs.2024.01.016
Nesrine Kacha , Gwendoline Dorel , Paul Frappé , Céline Chauleur , Tiphaine Raia-Barjat

Objective

Immersion in water during labor could reduce pain and use of epidural anesthesia during childbirth. The main objective of this study was to evaluate the influence of immersion in water during labor on the use of epidural anesthesia in a midwife care setting.

Methods

We conducted a single-center retrospective study of all women who gave birth in the physiological ward of Saint-Étienne University Hospital between October 2020 and December 2022.

Results

The study did not find difference between immersion group and control group concerning the use of epidural anesthesia (P = 0.49). The immersion group counted more women with a duration of labor greater than 6 hours than in the control group. The multivariate analysis adjusted for parity and duration of labor did not find difference between both groups [OR 0.58; 95% CI (0.30; 1.09)].

Conclusion

Even if it does not seem to modify the use of epidurals, immersion in water does not seem to increase maternal and neonatal morbidity and mortality. It represents a therapeutic alternative with reasonable cost to offer for pregnant women who wish to give birth without epidural anesthesia.

目的:在分娩过程中浸泡在水中可减少分娩时的疼痛和硬膜外麻醉的使用。本研究的主要目的是评估在助产士护理环境中,分娩时浸泡在水中对使用硬膜外麻醉的影响:我们对2020年10月至2022年12月期间在圣埃蒂安大学医院生理病房分娩的所有产妇进行了一项单中心回顾性研究:研究未发现浸泡组和对照组在硬膜外麻醉的使用方面存在差异(P = 0.49)。浸泡组中产程超过 6 小时的产妇人数多于对照组。根据胎次和产程调整后进行的多变量分析未发现两组之间存在差异(OR 0.58;95% CI [0.30;1.09]):尽管浸泡在水中似乎不会改变硬膜外麻醉的使用,但也不会增加产妇和新生儿的发病率和死亡率。对于希望在不使用硬膜外麻醉的情况下分娩的孕妇来说,这是一种成本合理的替代治疗方法。
{"title":"Influence de l’immersion dans l’eau sur le recours à la péridurale pendant le travail","authors":"Nesrine Kacha ,&nbsp;Gwendoline Dorel ,&nbsp;Paul Frappé ,&nbsp;Céline Chauleur ,&nbsp;Tiphaine Raia-Barjat","doi":"10.1016/j.gofs.2024.01.016","DOIUrl":"10.1016/j.gofs.2024.01.016","url":null,"abstract":"<div><h3>Objective</h3><p>Immersion in water during labor could reduce pain and use of epidural anesthesia during childbirth. The main objective of this study was to evaluate the influence of immersion in water during labor on the use of epidural anesthesia in a midwife care setting.</p></div><div><h3>Methods</h3><p>We conducted a single-center retrospective study of all women who gave birth in the physiological ward of Saint-Étienne University Hospital between October 2020 and December 2022.</p></div><div><h3>Results</h3><p>The study did not find difference between immersion group and control group concerning the use of epidural anesthesia (<em>P</em> <!-->=<!--> <!-->0.49). The immersion group counted more women with a duration of labor greater than 6<!--> <!-->hours than in the control group. The multivariate analysis adjusted for parity and duration of labor did not find difference between both groups [OR 0.58; 95% CI (0.30; 1.09)].</p></div><div><h3>Conclusion</h3><p>Even if it does not seem to modify the use of epidurals, immersion in water does not seem to increase maternal and neonatal morbidity and mortality. It represents a therapeutic alternative with reasonable cost to offer for pregnant women who wish to give birth without epidural anesthesia.</p></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 7","pages":"Pages 454-459"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139693640","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accouchement voie basse spontané compliqué d’un abcès du muscle ilio-psoas. À propos d’un cas et revue de la littérature [阴道分娩后髂腰肌脓肿:病例报告]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-07-01 DOI: 10.1016/j.gofs.2024.01.013
Asma Dali , Bilel Guidara , Jean-Daniel Hini
{"title":"Accouchement voie basse spontané compliqué d’un abcès du muscle ilio-psoas. À propos d’un cas et revue de la littérature","authors":"Asma Dali ,&nbsp;Bilel Guidara ,&nbsp;Jean-Daniel Hini","doi":"10.1016/j.gofs.2024.01.013","DOIUrl":"10.1016/j.gofs.2024.01.013","url":null,"abstract":"","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 7","pages":"Pages 490-491"},"PeriodicalIF":0.6,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Devenir clinique après transfert de blastocystes vitrifiés selon l’indication de congélation [玻璃化囊胚移植后的临床结果与冷冻适应症的关系]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-26 DOI: 10.1016/j.gofs.2024.06.002
Emmanuelle Bodin , Romane Sainte-Rose , Claire Petit , Marion Cornuau , Fabrice Guérif

Objectives

In France, embryo thawing concern 45.8% of attempts at assisted reproductive technologies excluding artificial inseminations. This proportion is constantly increasing for various reasons. The main objective of this study is to compare the live birth rate following frozen blastocyst transfer (FBT) according to the initial indication for freezing.

Methods

This is a retrospective study including patients who underwent FBT between 01/01/2020 and 06/30/2022 at the Regional University Hospital Center of Tours. The results were compared (univariate and multivariate analyses) between the three main indications for freezing: freezing of the complete cohort of blastocysts for risk of ovarian hyperstimulation (=OHS), freezing of supernumerary blastocysts after fresh blastocyst transfer (BT) with pregnancy (=second request) or without pregnancy (=BT failure). Results have also been described for other indications.

Results

Among the 963 FBT cycles selected, 28% of live births by thawing were obtained, all indications of freezing combined. A significantly lower rate was identified in the FBT failure group compared to the OHS group. However, after adjustment, the results remained significant for the age of the patient on the freezing cycle but not for the indication for freezing.

Conclusions

The outcome of a FBT does not seem significantly impacted by the indication of freezing considering the confounding factors. The prospective analysis of more data from a multicenter study would be necessary to confirm these results.
目的:在法国,除人工授精外,胚胎解冻占辅助生殖技术尝试的 45.8%。由于各种原因,这一比例在不断上升。本研究的主要目的是根据冷冻囊胚移植(FBT)的最初适应症,比较冷冻囊胚移植后的活产率:这是一项回顾性研究,包括 2020 年 1 月 1 日至 2022 年 6 月 30 日期间在图尔地区大学医院中心接受冷冻囊胚移植手术的患者。对三种主要冷冻适应症的结果进行了比较(单变量和多变量分析):因卵巢过度刺激(=OHS)风险而冷冻完整的囊胚群、冷冻新鲜囊胚移植(BT)后妊娠(=第二次要求)或未妊娠(=BT失败)的超数囊胚。结果:结果:在选定的 963 个 FBT 周期中,通过解冻获得活产的比例为 28%,所有冷冻适应症合并计算。与OHS组相比,FBT失败组的比例明显较低。然而,经过调整后,与冷冻周期中患者的年龄有关的结果仍然显著,但与冷冻适应症无关:考虑到各种混杂因素,冷冻适应症似乎对冷冻治疗的结果影响不大。有必要对一项多中心研究的更多数据进行前瞻性分析,以证实这些结果。
{"title":"Devenir clinique après transfert de blastocystes vitrifiés selon l’indication de congélation","authors":"Emmanuelle Bodin ,&nbsp;Romane Sainte-Rose ,&nbsp;Claire Petit ,&nbsp;Marion Cornuau ,&nbsp;Fabrice Guérif","doi":"10.1016/j.gofs.2024.06.002","DOIUrl":"10.1016/j.gofs.2024.06.002","url":null,"abstract":"<div><h3>Objectives</h3><div>In France, embryo thawing concern 45.8% of attempts at assisted reproductive technologies excluding artificial inseminations. This proportion is constantly increasing for various reasons. The main objective of this study is to compare the live birth rate following frozen blastocyst transfer (FBT) according to the initial indication for freezing.</div></div><div><h3>Methods</h3><div>This is a retrospective study including patients who underwent FBT between 01/01/2020 and 06/30/2022 at the Regional University Hospital Center of Tours. The results were compared (univariate and multivariate analyses) between the three main indications for freezing: freezing of the complete cohort of blastocysts for risk of ovarian hyperstimulation (=OHS), freezing of supernumerary blastocysts after fresh blastocyst transfer (BT) with pregnancy (=second request) or without pregnancy (=BT failure). Results have also been described for other indications.</div></div><div><h3>Results</h3><div>Among the 963 FBT cycles selected, 28% of live births by thawing were obtained, all indications of freezing combined. A significantly lower rate was identified in the FBT failure group compared to the OHS group. However, after adjustment, the results remained significant for the age of the patient on the freezing cycle but not for the indication for freezing.</div></div><div><h3>Conclusions</h3><div>The outcome of a FBT does not seem significantly impacted by the indication of freezing considering the confounding factors. The prospective analysis of more data from a multicenter study would be necessary to confirm these results.</div></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 12","pages":"Pages 690-696"},"PeriodicalIF":0.6,"publicationDate":"2024-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141473099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
La nouvelle version du site internet du Centre de référence sur les agents tératogènes et ses fonctionnalités optimisées [新版法国畸形信息服务网站 "CRAT"]。
IF 0.6 4区 医学 Q4 OBSTETRICS & GYNECOLOGY Pub Date : 2024-06-04 DOI: 10.1016/j.gofs.2024.05.005
Bénédicte Coulm , Delphine Beghin , Mathilde Latour , Bilal Majed , Catherine Vauzelle , Elisabeth Elefant , Benoît Marin
The Centre de Référence sur les Agents Tératogènes (CRAT) is a unique French national reference center involved in the risk assessment of exogenous agents (mainly drugs, but also medical imaging and addictions) on pregnancy, breastfeeding and fertility. To help improve patient care, CRAT makes its expertise available to healthcare professionals via its website (www.lecrat.fr), a free, independent and public online resource regularly updated by its multidisciplinary team. In December 2023, a new version was launched, based on the evolutions desired by the CRAT team and on a satisfaction survey of website's users. A predictive search bar integrated into the home page now enables users to find the specific information they are looking for more quickly. To optimize the access via smartphones, a mobile version is now available.
外源性药物风险评估中心(Centre de Référence sur les Agents Tératogènes (CRAT))是法国唯一一家从事外源性药物(主要是药物,也包括医学影像和成瘾药物)对妊娠、哺乳和生育风险评估的国家级参考中心。为了帮助改善患者护理,CRAT 通过其网站 (www.lecrat.fr) 向医疗保健专业人员提供其专业知识,该网站是一个免费、独立和公开的在线资源,由其多学科团队定期更新。2023 年 12 月,根据 CRAT 团队所希望的发展以及对网站用户的满意度调查,推出了新版本。现在,集成在主页上的预测搜索栏使用户能够更快地找到他们正在寻找的特定信息。为了优化智能手机的访问,现在还推出了手机版。
{"title":"La nouvelle version du site internet du Centre de référence sur les agents tératogènes et ses fonctionnalités optimisées","authors":"Bénédicte Coulm ,&nbsp;Delphine Beghin ,&nbsp;Mathilde Latour ,&nbsp;Bilal Majed ,&nbsp;Catherine Vauzelle ,&nbsp;Elisabeth Elefant ,&nbsp;Benoît Marin","doi":"10.1016/j.gofs.2024.05.005","DOIUrl":"10.1016/j.gofs.2024.05.005","url":null,"abstract":"<div><div>The Centre de Référence sur les Agents Tératogènes (CRAT) is a unique French national reference center involved in the risk assessment of exogenous agents (mainly drugs, but also medical imaging and addictions) on pregnancy, breastfeeding and fertility. To help improve patient care, CRAT makes its expertise available to healthcare professionals via its website (<span><span>www.lecrat.fr</span><svg><path></path></svg></span>), a free, independent and public online resource regularly updated by its multidisciplinary team. In December 2023, a new version was launched, based on the evolutions desired by the CRAT team and on a satisfaction survey of website's users. A predictive search bar integrated into the home page now enables users to find the specific information they are looking for more quickly. To optimize the access via smartphones, a mobile version is now available.</div></div>","PeriodicalId":56056,"journal":{"name":"Gynecologie Obstetrique Fertilite & Senologie","volume":"52 12","pages":"Pages 725-729"},"PeriodicalIF":0.6,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285400","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gynecologie Obstetrique Fertilite & Senologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1